Does RUXOLITINIB Cause Decreased activity? 558 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 558 reports of Decreased activity have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.8% of all adverse event reports for RUXOLITINIB.
558
Reports of Decreased activity with RUXOLITINIB
0.8%
of all RUXOLITINIB reports
9
Deaths
71
Hospitalizations
How Dangerous Is Decreased activity From RUXOLITINIB?
Of the 558 reports, 9 (1.6%) resulted in death, 71 (12.7%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Decreased activity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 558 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Decreased activity?
NIRAPARIB (586)
SACUBITRIL\VALSARTAN (570)
DUPILUMAB (231)
LEVOTHYROXINE (201)
TREPROSTINIL (195)
PREDNISONE (193)
ALBUTEROL (190)
EMTRICITABINE\TENOFOVIR DISOPROXIL (186)
TERIPARATIDE (156)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (145)
Which RUXOLITINIB Alternatives Have Lower Decreased activity Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE